Circulating Fibroblast Growth Factor 21 (Fgf21) as Diagnostic and Prognostic Biomarker in Renal Cancer

BACKGROUND: The finding of new biomarkers is needed to have a better sub-classification of primary renal tumors (RCC) as well as more reliable predictors of outcome and therapy response. In this study, we evaluated the role of circulating FGF21, an endocrine factor, as a diagnostic and prognostic bi...

Descripción completa

Detalles Bibliográficos
Autores principales: Knott, ME, Minatta, JN, Roulet, L, Gueglio, G, Pasik, L, Ranuncolo, SM, Nuñez, M, Puricelli, L, De Lorenzo, MS
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4922529/
https://www.ncbi.nlm.nih.gov/pubmed/27358750
http://dx.doi.org/10.4172/2155-9929.S2-015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4922529/
https://www.ncbi.nlm.nih.gov/pubmed/27358750
http://dx.doi.org/10.4172/2155-9929.S2-015

Ejemplares similares